Future Fields Biomanufacturing Ltd.: federal grants and contributions: 2 agreements; $1.9M value; 1 departments; 2 programs.
Assay record ASY-CA-0OLL0I217D · Cite as: Assay Systems, “Future Fields Biomanufacturing Ltd.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/future-fields-biomanufacturing-ltd/
Future Fields is an Edmonton-based biotech company that produces the most cost-effective and sustainable recombinant proteins in the world. The company has developed a novel insect-based expression platform that circumvents the challenges associated with legacy systems. In just 2 years, they have already launched 3 different products that are tailored to the needs of the cellular agriculture industry, a new and exciting field where traditional agriculture products, like milk or meat, can be created by culturing cells instead of raising animals.
This project will establish an in-house, automated Drosophila embryo microinjection platform to generate transgenic fly lines for R&D and commercial use. This will reduce costs and shorten timelines from plasmid to transgenic fly lines, and enable earlier testing of more construct variants, strengthening Alberta’s bio-based manufacturing capacity.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.